Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease

European Journal of Human Genetics

Volumn 23, Issue 10, 2015, Pages 1328-1333

  Schulte, Eva C ^a,b   Fukumori, Akio ^c,d   Mollenhauer, Brit ^e,f   Hor, Hyun ^g   Arzberger, Thomas ^c   Perneczky, Robert ^a,h   Kurz, Alexander ^a   Diehl Schmid, Janine ^a   Hüll, Michael ⁱ   Lichtner, Peter ^b,l   Eckstein, Gertrud ^b   Zimprich, Alexander ^k   Haubenberger, Dietrich ^k   Pirker, Walter ^k   Brücke, Thomas ^l   Bereznai, Benjamin ^m   Molnar, Maria J ^m   Lorenzo Betancor, Oswaldo ^n,o,p   Pastor, Pau ^n,o,p   Peters, Annette ^b   Gieger, Christian ^b   Estivill, Xavier ^g   Meitinger, Thomas ^b,j,q   Kretzschmar, Hans A ^c   Trenkwalder, Claudia ^e,f   Haass, Christian ^c,d,q   Winkelmann, Juliane ^a,b,j,q   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e Paracelsus Elena Klinik Kassel   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l WILHELMINEN HOSPITAL   (Austria)

^m SEMMELWEIS UNIVERSITY   (Hungary)

ⁿ UNIVERSITY OF NAVARRA   (Spain)

^o UNIVERSITY CLINIC OF NAVARRA   (Spain)

^p INSTITUTO DE SALUD CARLOS III   (Spain)

^q Technische Universität München Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; FUSED IN SARCOMA PROTEIN; PRESENILIN 1; PRESENILIN 2; TAR DNA BINDING PROTEIN; TAU PROTEIN; DNA BINDING PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; GRANULIN GENE; HEK293 CELL LINE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; CELL LINE; DEGENERATIVE DISEASE; DEMENTIA; GENETIC VARIATION; GENETICS; GENOTYPE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HEK293 CELLS; HUMANS; MALE; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE;

EID: 84944146256     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.300     Document Type: Article

References (25)

1. Deramecourt V, Bombois S, Maurage CA et al: Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 2006; 65: 278-288.
2. Hutton M, Lendon CL, Rizzu P et al: Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
3. Pastor P, Ezquerra M, Munoz E et al: Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann Neurol 2000; 47: 242-245.
4. Simon-Sanchez J, Schulte C, Bras JM et al: Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308-1312.
5. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P: Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-392.
6. Riedel O, Klotsche J, Spottke A et al: Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008; 255: 255-264.
7. Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ.: Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain 2010; 133: 1755-1762.
8. Goate A, Chartier-Harlin MC, Mullan M et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
9. Levy-Lahad E, Wasco W, Poorkaj P et al: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-977.
10. Rogaev EI, Sherrington R, Rogaeva EA et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-778.
11. Sherrington R, Rogaev EI, Liang Y et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-760.
12. Cruts M, Gijselinck I, van der Zee J et al: Null mutations in progranulin cause ubiquitinpositive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-924.
13. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR.: A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132: 2922-2931.
14. Neumann M, Sampathu DM, Kwong LK et al: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
15. Emre M, Aarsland D, Brown R et al: Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-1707, quiz 1837.
16. Winkelmann J, Czamara D, Schormair B et al: Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011; 7: e1002171.
17. (ESP) NGESP. Exome Variant Server. Available at http://evs.gs.washington.edu/EVS/Accessed on December 1, 2012.
18. Lei P, Ayton S, Finkelstein DI et al: Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 2012; 18: 291-295.
19. Ross OA, Soto-Ortolaza AI, Heckman MG et al: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011; 10: 898-908.
20. Guo JP, Arai T, Miklossy J, McGeer PL: Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc Natl Acad Sci USA 2006;103:1953-1958.
21. Ousson S, Saric A, Baguet A et al: Substrate determinants in the C99 juxtamembrane domains differentially affect gamma-secretase cleavage specificity and modulator pharmacology. J Neurochem 2013; 125: 610-619.
22. Haass C, Kaether C, Thinakaran G, Sisodia S: Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2012; 2: a006270.
23. Duce JA, Ayton S, Miller AA et al: Amine oxidase activity of beta-amyloid precursor protein modulates systemic and local catecholamine levels. Mol Psychiatry 2013; 18: 245-254.
24. Duce JA, Tsatsanis A, Cater MA et al: Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010; 142: 857-867.
25. Dexter DT, Wells FR, Agid F et al: Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987; 2: 1219-1220.